Unichem US market share loss persists
Unichem lost market share in key US products; decline may continue for 1-2 more quarters, pressuring margins.
high · management_commentaryIPCA Laboratories Ltd — Q3 FY26
IPCA Laboratories delivered a solid Q3 FY26 with consolidated revenue of ₹2,245 crore (+6.5% YoY) and consolidated EBITDA margin expanding 228 bps YoY to 22.15%.
bullish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
UK generic pricing pressure
UK generic market experienced severe price erosion; though recent recovery of 30-40% seen, sustainability uncertain.
medium · management_commentaryDependence on IKA portfolio for US growth
US growth largely driven by IKA portfolio; organic IPA US business still small (~₹10-11M in 9 months).
medium · data_observationCurrency volatility in branded export markets
Promotional branded business is stable but can be impacted by currency fluctuations in emerging markets.
low · management_commentary